This handbook is a reference tool for use by national tuberculosis (TB) program managers, clinicians and nurses, public health decision-makers and technical and implementing partners committed to the prevention, care, diagnosis and treatment of drug-resistant TB.
These new guidelines supersede previous WHO policy documents on the management of LTBI in people living with HIV, household contacts of people with active TB, other groups at risk of developing TB, and for LTBI testing. The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants.
This roadmap describes ten priorities, grouped into three core themes, that address the major health and economic impacts of zoonotic TB.
This is a planning document designed to facilitate the integration of strong public-private mix components into national TB strategic plans that are supposed to be the basis for Global Fund proposals and national budgeting processes, and will help drive a more comprehensive approach to provider engagement in TB care and prevention.
The book provides basic information on the use of the public health and clinical laboratories in the diagnosis and monitoring of patients with latent tuberculosis infection(LTBI) and tuberculosis(TB) disease.
This handbook focuses specifically on three technologies that are being widely used to help TB patients complete their treatment over the many months that their regimens last.
